(Q45542064)

14 December 2017

title

Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancer (English)

1 reference

14 December 2017

3

1 reference

14 December 2017

10

1 reference

14 December 2017

Lisa McGee

1

1 reference

14 December 2017

Nancy P Mendenhall

2

1 reference

14 December 2017

Christopher G Morris

4

1 reference

14 December 2017

Romaine C Nichols

5

1 reference

14 December 2017

Robert J Marcus

6

1 reference

14 December 2017

Zuofeng Li

7

1 reference

14 December 2017

William M Mendenhall

8

1 reference

14 December 2017

Christopher R Williams

9

1 reference

14 December 2017

publication date

17 December 2012

1 reference

14 December 2017

1 reference

14 December 2017

volume

52

1 reference

14 December 2017

issue

3

1 reference

14 December 2017

page(s)

470-476

1 reference

Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study.

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.744467

Prostatic length predicts functional outcomes after iodine-125 prostate brachytherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.744467

The impact of prostate size on perioperative outcomes in a large laparoscopic radical prostatectomy series

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.744467

Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.744467

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.744467

The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.744467

High-dose-rate brachytherapy for large prostate volumes (> or =50cc)-Uncompromised dosimetric coverage and acceptable toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.744467

Association of prostate size with urinary morbidity following mixed conformal neutron and photon irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.744467

Quality of life in prostate cancer patients taking androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.744467

Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.744467

Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.744467

10.3109/0284186X.2012.744467

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference